53.64
1.09%
+0.58
After Hours:
53.64
Globus Medical Inc stock is currently priced at $53.64, with a 24-hour trading volume of 722.14K.
It has seen a +1.09% increased in the last 24 hours and a -1.51% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $52.73 pivot point. If it approaches the $54.11 resistance level, significant changes may occur.
Globus Medical Inc Stock (GMED) Financials Data
Globus Medical Inc (GMED) Revenue 2023
GMED reported a revenue (TTM) of $1.57 billion for the quarter ending December 31, 2023, a +53.34% rise year-over-year.
Globus Medical Inc (GMED) Net Income 2023
GMED net income (TTM) was $122.87 million for the quarter ending December 31, 2023, a -35.39% decrease year-over-year.
Globus Medical Inc (GMED) Cash Flow 2023
GMED recorded a free cash flow (TTM) of $165.22 million for the quarter ending December 31, 2023, a +58.23% increase year-over-year.
Globus Medical Inc (GMED) Earnings per Share 2023
GMED earnings per share (TTM) was $1.17 for the quarter ending December 31, 2023, a -37.10% decline year-over-year.
Globus Medical Inc Stock (GMED) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Norwalk Leslie V | Director |
Mar 15 '24 |
Sale |
51.99 |
10,590 |
550,574 |
17,419 |
Huller Kelly | SVP, GC, Corporate Secretary |
Mar 01 '24 |
Option Exercise |
24.90 |
7,500 |
186,750 |
7,500 |
Huller Kelly | SVP, GC, Corporate Secretary |
Mar 01 '24 |
Sale |
54.10 |
7,500 |
405,730 |
0 |
Lemaitre Dan | Director |
May 15 '23 |
Option Exercise |
25.43 |
43,450 |
1,104,782 |
54,250 |
Lemaitre Dan | Director |
May 15 '23 |
Sale |
56.98 |
43,450 |
2,475,977 |
10,800 |
Globus Medical Inc Stock (GMED) Latest News
Globus Medical (GMED) Down 5.8% Since Last Earnings Report: Can It Rebound?
Zacks Investment Research
The Latest Analyst Ratings For Globus Medical
Benzinga
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Zacks Investment Research
Here's Why You Should Retain Globus Medical (GMED) Stock Now
Zacks Investment Research
Here's Why Globus Medical (GMED) is a Strong Value Stock
Zacks Investment Research
Here's Why Globus Medical (GMED) is a Strong Momentum Stock
Zacks Investment Research
About Globus Medical Inc
Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The company offers products that address an array of spinal pathologies, anatomies, and surgical approaches. Its fusion products include a range of implant and surgical approach options to treat degenerative, deformity, tumor, and trauma conditions along the spine from the occiput to the sacrum. The company's disruptive technology products comprise products that allow for minimally invasive surgical techniques; and new treatment alternatives, including imaging, navigational, and robotic technologies, as well as motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous process spacer products. Its disruptive technology products also consist of regenerative biologics products, including bioactive glass-based bone void fillers and ceramic-collagen for pelvic/extremity and posterolateral spinal fusion procedures; and interventional pain management solutions, which comprise treatments for vertebral compression fractures. In addition, the company offers products for the treatment of orthopedic trauma, including compression screws, fixation plates, intramedullary nails, and external fixation systems. Further, it distributes human cell, tissue, and cellular and tissue based products. The company sells its implants and related disposables primarily to hospitals through direct sales representatives and independent distributors in the United States and internationally. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.
Cap:
|
Volume (24h):